Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven-Eric Schelhorn

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cognitive Processing|January 20, 2007
Transformational and derivational strategies in analogical problem solvingSven-Eric Schelhorn, Jacqueline Griego, Ute Schmid
Bioinformatics (Oxford, England)|August 12, 2008
An integrative approach for predicting interactions of protein regionsSven-Eric Schelhorn, Thomas Lengauer, Mario Albrecht
Genome Biology|July 2, 2013
The DNA60IFX contestMichael C Schatz, James Taylor, Sven-Eric Schelhorn
Molecular & Cellular Proteomics : MCP|April 1, 2011
Inferring physical protein contacts from large-scale purification data of protein complexesSven-Eric Schelhorn, Julián Mestre, Mario Albrecht, et al.
Bioinformatics (Oxford, England)|November 17, 2007
Computing topological parameters of biological networksYassen Assenov, Fidel Ramírez, Sven-Eric Schelhorn, et al.
Plos Computational Biology|October 8, 2013
Sensitive detection of viral transcripts in human tumor transcriptomesSven-Eric Schelhorn, Matthias Fischer, Laura Tolosi, et al.
Nature Communications|December 14, 2023
Mapping combinatorial drug effects to DNA damage response kinase inhibitorsHanrui Zhang, Julian Kreis, Sven-Eric Schelhorn, et al.
Neoplasia (New York, N.Y.)|September 28, 2021
RosettaSX: Reliable gene expression signature scoring of cancer models and patientsJulian Kreis, Boro Nedić, Johanna Mazur, et al.
Bioinformatics (Oxford, England)|May 8, 2009
DASMI: exchanging, annotating and assessing molecular interaction dataHagen Blankenburg, Robert D Finn, Andreas Prlić, et al.
Scientific Reports|November 21, 2023
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignanciesSamantha M Goodstal, Jing Lin, Timothy Crandall, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cognitive Processing|January 20, 2007
Transformational and derivational strategies in analogical problem solvingSven-Eric Schelhorn, Jacqueline Griego, Ute Schmid
Bioinformatics (Oxford, England)|August 12, 2008
An integrative approach for predicting interactions of protein regionsSven-Eric Schelhorn, Thomas Lengauer, Mario Albrecht
Genome Biology|July 2, 2013
The DNA60IFX contestMichael C Schatz, James Taylor, Sven-Eric Schelhorn
Molecular & Cellular Proteomics : MCP|April 1, 2011
Inferring physical protein contacts from large-scale purification data of protein complexesSven-Eric Schelhorn, Julián Mestre, Mario Albrecht, et al.
Bioinformatics (Oxford, England)|November 17, 2007
Computing topological parameters of biological networksYassen Assenov, Fidel Ramírez, Sven-Eric Schelhorn, et al.
Plos Computational Biology|October 8, 2013
Sensitive detection of viral transcripts in human tumor transcriptomesSven-Eric Schelhorn, Matthias Fischer, Laura Tolosi, et al.
Nature Communications|December 14, 2023
Mapping combinatorial drug effects to DNA damage response kinase inhibitorsHanrui Zhang, Julian Kreis, Sven-Eric Schelhorn, et al.
Neoplasia (New York, N.Y.)|September 28, 2021
RosettaSX: Reliable gene expression signature scoring of cancer models and patientsJulian Kreis, Boro Nedić, Johanna Mazur, et al.
Bioinformatics (Oxford, England)|May 8, 2009
DASMI: exchanging, annotating and assessing molecular interaction dataHagen Blankenburg, Robert D Finn, Andreas Prlić, et al.
Scientific Reports|November 21, 2023
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignanciesSamantha M Goodstal, Jing Lin, Timothy Crandall, et al.
Pageof 2